search
Back to results

Neural, Behavioural, and Clinical Effects of tDCS in PDOC; Feasibility Study (RAINDROP)

Primary Purpose

Consciousness Disorder, Brain Injuries, Vegetative State

Status
Unknown status
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Transcranial direct current stimulation
Sponsored by
University of Birmingham
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Consciousness Disorder

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Aged 18 years or older
  • Receiving care at a recruitment site, with a consensus clinical diagnosis of PDOC from any aetiology (i.e. traumatic or non-traumatic injury).
  • Stable and with no need of mechanical support (i.e. respirator, etc.)

Exclusion Criteria:

  • Scalp skin sores or any skin damage at the electrode sites
  • Metallic implants in the face or skull
  • Craniectomy or cranioplasty
  • No evidence of auditory startle in clinical observations, or absent brainstem auditory evoked potentials in recent clinical history (if data available)
  • MRI incompatible: metal plates incompatible with MRI scanners, pacemaker, inability to lay flat for prolonged periods of time, aneurysm clips, neurostimulators, brain/subdural electrodes, etc. (MRI stream ONLY)

Sites / Locations

  • Moseley Hall Hospital
  • The Wellington Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

MRI stream

Bedside stream

Arm Description

In this stream all patients receive 2 experimental interventions (anodal tDCS and cathodal tDCS) and a sham intervention (sham tDCS). These are delivered in randomised order, ensuring a balanced distribution of participants across possible orders. They will receive 5 sessions per condition (on consecutive days), for a total of 15 sessions. I. Anodal, cathodal, sham II. Anodal, sham, cathodal III. Cathodal, anodal, sham IV. Cathodal, sham, anodal V. Sham, anodal, cathodal VI. Sham, cathodal, anodal

In this stream all patients receive 1 experimental interventions (either anodal tDCS or cathodal tDCS) and 1 sham intervention (sham tDCS). These include only 1 session per condition and are delivered in randomised order, resulting in the following possible combinations: I. Anodal, sham II. Cathodal, sham III. Sham, anodal IV. Sham, cathodal Participants will be randomly assigned to the above groups ensuring a balanced distribution of participants across them.

Outcomes

Primary Outcome Measures

Retention at end of active phase
percentage of participants on study at pre-specified time points counted from the start of participation in the study (i.e., first study procedure)
Retention at 3 months
percentage of participants on study at pre-specified time points counted from the start of participation in the study (i.e., first study procedure). This Outcome applies to the bedside stream only
Retention at 6 months
percentage of participants on study at pre-specified time points counted from the start of participation in the study (i.e., first study procedure). This Outcome applies to the bedside stream only
Completion
percentage of tDCS, MRI, and electrophysiology assessments completed per polarity

Secondary Outcome Measures

Structural MRI
This will include assessments of the gross macrostructure, and microstructure of brain tissue grey matter, white matter, and cerebrospinal fluid
Functional MRI in response to task instructions
This will include assessments of the BOLD (blood oxygen level-dependent) response to characterise brain activity and connectivity during command following
EEG power in the alpha band in response to task instructions
Envelope of bandpass filtered EEG data between 8-12 Hertz
EEG power in the beta band in response to task instructions
Envelope of bandpass filtered EEG data between 13-30 Hertz
EMG (electromyography) amplitude changes
Changes in the amplitude of the rectified EMG signal (high-pass filtered > 50Hz) in response to instructions to move
Coma recovery scale -revised
clinical diagnostic scale for disorders of consciousness. Total score ranges from 0 to 23, where higher scores mean a higher level of functioning and awareness
Glasgow Outcome Scale-extended
Scale for functional outcome after brain injury. Total score ranges from 1 to 8, where higher values correspond to better outcome

Full Information

First Posted
January 22, 2020
Last Updated
April 30, 2021
Sponsor
University of Birmingham
Collaborators
Wellington Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04248946
Brief Title
Neural, Behavioural, and Clinical Effects of tDCS in PDOC; Feasibility Study
Acronym
RAINDROP
Official Title
Sham-controlled, Double-blind, Randomised Crossover Study of the Neural, Behavioural, and Clinical Effects of Transcranial Direct Current Stimulation in Patients With a Prolonged Disorder of Consciousness; Feasibility Study
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Unknown status
Study Start Date
July 2021 (Anticipated)
Primary Completion Date
August 2022 (Anticipated)
Study Completion Date
August 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Birmingham
Collaborators
Wellington Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study evaluates the feasibility of an experimental protocol that combines advanced multi-modal imaging of the brain with clinical and behavioural scales to characterise the neural, behavioural, and clinical effects of transcranial direct current stimulation (tDCS) for rehabilitation in PDOC
Detailed Description
Patients with prolonged disorders of consciousness (PDOC) have very limited therapeutic options, and they often show little to no progress over time. Here, the investigators will assess whether transcranial direct current stimulation can improve patients' responsiveness. The investigators will use a protocol designed to target specific brain networks that have been shown to play a key role in explaining the lack of voluntary responses in PDOC. The study will focus on characterising the mechanisms of action of tDCS and the bases for potential individual differences in responsiveness to the stimulation across participants. This feasibility study is the first step towards developing personalised tDCS interventions to restore external responsiveness in PDOC patients. Its results will inform the design of a future trial fully powered for characterising neural, behavioural, and clinical effects of tDCS in PDOC as well as the mechanisms underlying individual differences in responsiveness.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Consciousness Disorder, Brain Injuries, Vegetative State, Minimally Conscious State

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
This is a double-blind randomised crossover feasibility study of tDCS in a small cohort of PDOC individuals. The study is divided into two streams to accommodate differences in the resources available across recruitment sites: 1. MRI stream, which will include MRI and electrophysiology assessments; this is available to patients receiving care at the Wellington Hospital in London only. 2. Bedside stream, which will include electrophysiology assessments only, available to patients in specialist units at NHS (National Health Service) and non-NHS sites
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
In the MRI stream all participants will receive anodal, cathodal, and sham (placebo) tDCS sessions in a randomised order. In the Bedside stream participants will receive active tDCS (either anodal or cathodal) and sham sessions also in a randomised order. A researcher not involved in data collection or analyses will programme the stimulator to deliver the specific polarity needed in each session in a double-blind manner. Sham tDCS will be delivered according to published guidelines: this mimics the physical sensations of active stimulation but does not have a neuromodulatory effect
Allocation
Non-Randomized
Enrollment
15 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
MRI stream
Arm Type
Experimental
Arm Description
In this stream all patients receive 2 experimental interventions (anodal tDCS and cathodal tDCS) and a sham intervention (sham tDCS). These are delivered in randomised order, ensuring a balanced distribution of participants across possible orders. They will receive 5 sessions per condition (on consecutive days), for a total of 15 sessions. I. Anodal, cathodal, sham II. Anodal, sham, cathodal III. Cathodal, anodal, sham IV. Cathodal, sham, anodal V. Sham, anodal, cathodal VI. Sham, cathodal, anodal
Arm Title
Bedside stream
Arm Type
Experimental
Arm Description
In this stream all patients receive 1 experimental interventions (either anodal tDCS or cathodal tDCS) and 1 sham intervention (sham tDCS). These include only 1 session per condition and are delivered in randomised order, resulting in the following possible combinations: I. Anodal, sham II. Cathodal, sham III. Sham, anodal IV. Sham, cathodal Participants will be randomly assigned to the above groups ensuring a balanced distribution of participants across them.
Intervention Type
Other
Intervention Name(s)
Transcranial direct current stimulation
Other Intervention Name(s)
tDCS
Intervention Description
tDCS alters neural excitability in a polarity-specific manner via a weak direct electric current delivered through electrodes placed on the scalp. There are 3 types of stimulation: anodal, cathodal, and sham. In anodal tDCS, the positive electrode is placed over the target brain area to increase neuronal excitability. In cathodal tDCS, the negative electrode is placed over the target brain area to decrease neuronal excitability. Sham tDCS emulates the physical sensations of active (anodal/cathodal) tDCS but current is only delivered for a short period of time and is not enough to cause any neuromodulations
Primary Outcome Measure Information:
Title
Retention at end of active phase
Description
percentage of participants on study at pre-specified time points counted from the start of participation in the study (i.e., first study procedure)
Time Frame
through completion of active phase of study (tDCS intervention), on average 4 weeks for bedside stream and 8 weeks for MRI stream
Title
Retention at 3 months
Description
percentage of participants on study at pre-specified time points counted from the start of participation in the study (i.e., first study procedure). This Outcome applies to the bedside stream only
Time Frame
3 months after start of participation
Title
Retention at 6 months
Description
percentage of participants on study at pre-specified time points counted from the start of participation in the study (i.e., first study procedure). This Outcome applies to the bedside stream only
Time Frame
6 months after start of participation
Title
Completion
Description
percentage of tDCS, MRI, and electrophysiology assessments completed per polarity
Time Frame
through completion of active phase of study (tDCS intervention), on average 4 weeks for bedside stream and 8 weeks for MRI stream
Secondary Outcome Measure Information:
Title
Structural MRI
Description
This will include assessments of the gross macrostructure, and microstructure of brain tissue grey matter, white matter, and cerebrospinal fluid
Time Frame
day 1 and day 5 of tDCS each polarity
Title
Functional MRI in response to task instructions
Description
This will include assessments of the BOLD (blood oxygen level-dependent) response to characterise brain activity and connectivity during command following
Time Frame
day 1 and day 5 of tDCS each polarity
Title
EEG power in the alpha band in response to task instructions
Description
Envelope of bandpass filtered EEG data between 8-12 Hertz
Time Frame
days 1 and 4 of each polarity in the MRI stream and day 1 of each polarity in the bedside stream
Title
EEG power in the beta band in response to task instructions
Description
Envelope of bandpass filtered EEG data between 13-30 Hertz
Time Frame
days 1 and 4 of each polarity in the MRI stream and day 1 of each polarity in the bedside stream
Title
EMG (electromyography) amplitude changes
Description
Changes in the amplitude of the rectified EMG signal (high-pass filtered > 50Hz) in response to instructions to move
Time Frame
days 1-4 and day 2 of each polarity in the MRI and bedside streams respectively
Title
Coma recovery scale -revised
Description
clinical diagnostic scale for disorders of consciousness. Total score ranges from 0 to 23, where higher scores mean a higher level of functioning and awareness
Time Frame
regularly through active phase of study (baseline and outcome assessments), on average 4 weeks for bedside stream and 8 weeks for MRI stream
Title
Glasgow Outcome Scale-extended
Description
Scale for functional outcome after brain injury. Total score ranges from 1 to 8, where higher values correspond to better outcome
Time Frame
at 3 and 6 months after start of participation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Aged 18 years or older Receiving care at a recruitment site, with a consensus clinical diagnosis of PDOC from any aetiology (i.e. traumatic or non-traumatic injury). Stable and with no need of mechanical support (i.e. respirator, etc.) Exclusion Criteria: Scalp skin sores or any skin damage at the electrode sites Metallic implants in the face or skull Craniectomy or cranioplasty No evidence of auditory startle in clinical observations, or absent brainstem auditory evoked potentials in recent clinical history (if data available) MRI incompatible: metal plates incompatible with MRI scanners, pacemaker, inability to lay flat for prolonged periods of time, aneurysm clips, neurostimulators, brain/subdural electrodes, etc. (MRI stream ONLY)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Davinia Fernandez Espejo, PhD FHEA
Phone
01214145534
Email
d.fernandez-espejo@bham.ac.uk
Facility Information:
Facility Name
Moseley Hall Hospital
City
Birmingham
State/Province
West Midlands
ZIP/Postal Code
B13 8JL
Country
United Kingdom
Facility Name
The Wellington Hospital
City
London
ZIP/Postal Code
NW8 9LE
Country
United Kingdom
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Antonio Incisa, PhD CPsychol CSci
Phone
+44 (0)20 7483 5595
Email
Antonio.Incisa@HCAHealthcare.co.uk

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Neural, Behavioural, and Clinical Effects of tDCS in PDOC; Feasibility Study

We'll reach out to this number within 24 hrs